CinDome Pharma
PrivateLast Round
VC Round
Jun 4, 2025
Total Funding Raised
$59M
Company Overview
CinDome Pharma is a biopharmaceutical company that develops deudomperidone (CIN-102) as a chronic treatment for gastroparesis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CinDome Pharma Comparables
Compare CinDome Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aclipse Therapeutics | 86% | |
| Renexxion, Inc. | 85% | |
| Neurogastrx | 85% |
CinDome Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 4, 2025 | ||||
| Series B Extension | May 16, 2024 | ||||
| Series B | Apr 27, 2023 |
CinDome Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CinRx Pharma | Series B Extension, VC Round, Series B |
| Perceptive Advisors | Series B Extension, VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
$40M round with Perceptive Advisors and CinRx Pharma.
- May 16, 2024
$40M round with Perceptive Advisors and CinRx Pharma.
CinDome Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CinDome Pharma's valuation, stock price, and market status.
Is CinDome Pharma a public or private company?
CinDome Pharma is a private company.
What is the current stock price of CinDome Pharma?
CinDome Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is CinDome Pharma worth (valuation)?
Valuation information for CinDome Pharma is not publicly available.
Can I buy CinDome Pharma stock?
CinDome Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CinDome Pharma's last funding round?
CinDome Pharma's most recent funding round was VC Round on June 4, 2025.
Who are the main investors in CinDome Pharma?
Key investors in CinDome Pharma include CinRx Pharma, Perceptive Advisors.
Will CinDome Pharma IPO soon?
No public IPO plans have been announced for CinDome Pharma.
How can I track CinDome Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CinDome Pharma's secondary market activity and sign up for updates.